Not finding it? Sign in to also search OpenAlex live.
-
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study2023 Infectious Diseases and Therapy article Medicine COVID-19 Clinical Research Studies Open access
Emiel Leegwater, Lisa Dol, Menno R. Bénard, Eveline E. Roelofsen, Nathalie Manon Delfos, Machteld van der Feltz, +14 more
0citations -
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients2022 Antimicrobial Agents and Chemotherapy article Medicine COVID-19 Clinical Research Studies Open access
Emiel Leegwater, Dirk Jan A. R. Moes, Liesbeth B. E. Bosma, Thomas H. Ottens, Irene M. van der Meer, Cees van Nieuwkoop, +1 more
25citations -
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells2022 European Journal of Pharmaceutical Sciences article Medicine SARS-CoV-2 and COVID-19 Research Open access
Mohammed A. A. Saleh, Makoto Hirasawa, Ming Sun, Berfin Gülave, Jeroen Elassaiss‐Schaap, Elizabeth C. M. de Lange
10citations -
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-192021 Zenodo (CERN European Organization for Nuclear Research) dataset Decision Sciences Meta-analysis and systematic reviews Open access
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, Volker Thieme, Maria‐Inti Metzendorf, Nicole Stortz, +5 more
0citations -
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-192021 Zenodo (CERN European Organization for Nuclear Research) dataset Decision Sciences Meta-analysis and systematic reviews Open access
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, Agata Mikołajewska, Volker Thieme, Vanessa Piechotta, +4 more
0citations -
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-192021 Zenodo (CERN European Organization for Nuclear Research) dataset Decision Sciences Meta-analysis and systematic reviews Open access
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, Volker Thieme, Maria‐Inti Metzendorf, Nicole Stortz, +5 more
0citations -
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-192021 Zenodo (CERN European Organization for Nuclear Research) dataset Decision Sciences Meta-analysis and systematic reviews Open access
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, Agata Mikołajewska, Volker Thieme, Vanessa Piechotta, +4 more
0citations -
Remdesivir for COVID-19 in Europe: will it provide value for money?2020 The Lancet Respiratory Medicine article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Rafael Dal‐Ré, Rita Banzi, Sophie Georgin‐Lavialle, Raphaël Porcher, Reecha Sofat, Markus Alexander Zeitlinger, +1 more
15citations -
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands
Marleen A. Slim, Brent Appelman, Hessel Peters Sengers, Dave Anton Dongelmans, Nicolette F. de Keizer, Rogier P. Schade, +21 more
13citations -
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology2020 Journal of General Virology article Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 17 patents
Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe, Ronald W.A.L. Limpens, Leon Caly, Julian D Druce, +5 more
557citations -
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access cited by 17 patents
Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe, Ronald W.A.L. Limpens, Leon Caly, Julian D Druce, +5 more
70citations -
Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-22021 Viruses article Biochemistry, Genetics and Molecular Biology Cell Image Analysis Techniques Open access cited by 1 patent
Raphael M. Kronberg, Paweł Stachura, Philipp Niklas Ostermann, Lisa Müller, Heiner Schaal, Sanil Bhatia, +5 more
18citations -
LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial
Jane A. O’Halloran, Kevin Joseph Anstrom, Eyal Kedar, Matthew William McCarthy, Emily R. Ko, Richard Melsheimer, +4 more
0citations